PMID- 7779737
OWN - NLM
STAT- MEDLINE
DCOM- 19950719
LR  - 20220311
IS  - 0007-0920 (Print)
IS  - 1532-1827 (Electronic)
IS  - 0007-0920 (Linking)
VI  - 71
IP  - 6
DP  - 1995 Jun
TI  - Incidence, mortality and survival in cancer of the cervix in Bangalore, India.
PG  - 1348-52
AB  - Cancer of the cervix is the most common cancer among women in India, constituting 
      between one-sixth to one-half of all female cancers with an age-adjusted 
      incidence rate ranging from 19.4 to 43.5 per 100,000 in the registries under the 
      National Cancer Registry Programme (NCRP) (Annual Reports, NCRP, ICMR). It has 
      been estimated that 100,000 new cases of cancer of the cervix occur in India 
      every year, and 70% or more of these are Stage III or higher at diagnosis. 
      However, the incidence of cancer of the cervix as suggested in this report 
      appears to be on the decline in Bangalore. Besides incidence and clinical stage 
      at presentation knowledge of survival is essential to complete the picture of 
      establishing baseline indicators to monitor and evaluate cancer control 
      programmes. Survival analysis was carried out in 2121 patients diagnosed during 
      1982-89 in the population of Bangalore, India. The observed 5 year survival was 
      34.4% and the relative survival 38.3%. Clinical stage at presentation was the 
      single most important variable in predicting survival. The 5 year observed 
      survival for stage I disease was 63.3%, for stage II 44.0%, for stage III 30.3% 
      and for stage IV 5.7%.
FAU - Nandakumar, A
AU  - Nandakumar A
AD  - Coordinating Unit, National Cancer Registry Programme of India (Indian Council of 
      Medical Research), Kidwai Memorial Institute of Oncology, Bangalore.
FAU - Anantha, N
AU  - Anantha N
FAU - Venugopal, T C
AU  - Venugopal TC
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Br J Cancer
JT  - British journal of cancer
JID - 0370635
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Demography
MH  - Education
MH  - Female
MH  - Humans
MH  - Incidence
MH  - India/epidemiology
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Predictive Value of Tests
MH  - Proportional Hazards Models
MH  - Registries
MH  - Regression Analysis
MH  - Religion
MH  - Survival Rate
MH  - Uterine Cervical Neoplasms/*epidemiology/mortality/pathology
PMC - PMC2033817
OID - PIP: 107193
OID - POP: 00245532
OAB - Cervical cancer is the most common form of cancer among women in India, with an 
      estimated 100,000 new cases developing annually in the country. 70% or more of 
      these cases are stage 3 or higher at diagnosis. When establishing baseline 
      indicators to monitor and evaluate cancer control programs, it is necessary to 
      have incidence, clinical stage at presentation, and survival data on the disease. 
      This paper presents findings from the analysis of survival data on 2121 patients 
      diagnosed with cervical cancer during 1982-89 in the population of Bangalore, 
      India. The observed five-year survival was 34.4%, while relative survival was 
      38.3%. Clinical stage at presentation was the single most important variable in 
      predicting survival. More precisely, the five-year observed survival for stage 1 
      disease was 63.5%, 44.0% for stage 2, 30.3% for stage 3, and 5.7% for stage 4.
OABL- eng
OTO - PIP
OT  - Asia
OT  - Cancer
OT  - *Cervical Cancer
OT  - Demographic Factors
OT  - Developing Countries
OT  - Diseases
OT  - *Incidence
OT  - India
OT  - Information
OT  - Information Processing
OT  - Measurement
OT  - *Mortality--women
OT  - Neoplasms
OT  - Population
OT  - Population Characteristics
OT  - Population Dynamics
OT  - *Records
OT  - Research Methodology
OT  - *Research Report
OT  - *Retrospective Studies
OT  - Southern Asia
OT  - Studies
OT  - *Urban Population--women
EDAT- 1995/06/01 00:00
MHDA- 1995/06/01 00:01
CRDT- 1995/06/01 00:00
PHST- 1995/06/01 00:00 [pubmed]
PHST- 1995/06/01 00:01 [medline]
PHST- 1995/06/01 00:00 [entrez]
AID - 10.1038/bjc.1995.262 [doi]
PST - ppublish
SO  - Br J Cancer. 1995 Jun;71(6):1348-52. doi: 10.1038/bjc.1995.262.